Sodium Hexafluorozirconate

SECTION 1. IDENTIFICATION

Product Name: Sodium Hexafluorozirconate

Product Number: All applicable American Elements product codes, e.g. NA-FZRO6-018

CAS #: 16925-26-1

Relevant identified uses of the substance: Scientific research and development

Supplier details:
American Elements
10884 Weyburn Ave.
Los Angeles, CA 90024
Tel: +1 310-208-0551
Fax: +1 310-208-0351

Emergency telephone number:
Domestic, North America: +1 800-424-9300
International: +1 703-527-3887

SECTION 2. HAZARDS IDENTIFICATION

2.1 Classification of the substance or mixture
GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)
Skin corrosion (Category 1B), H314
Serious eye damage (Category 1), H318

2.2 GHS Label elements, including precautionary statements
Pictogram

Signal word Danger
Hazard statement(s)
H314 Causes severe skin burns and eye damage.
Precautionary statement(s)
P260 Do not breathe dust or mist.
P264 Wash skin thoroughly after handling.
P280 Wear protective gloves/ protective clothing/ eye protection/ face
protection.
P301 + P330 + P331 IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P303 + P361 + P353 IF ON SKIN (or hair): Remove/ Take off immediately all contaminated
clothing. Rinse skin with water/ shower.
P304 + P340 IF INHALED: Remove victim to fresh air and keep at rest in a position
comfortable for breathing.
P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove
contact lenses, if present and easy to do. Continue rinsing.
P310 Immediately call a POISON CENTER/doctor.
P321 Specific treatment (see supplemental first aid instructions on this label).
P363 Wash contaminated clothing before reuse.
P405 Store locked up.
P501 Dispose of contents/ container to an approved waste disposal plant.
2.3 Hazards not otherwise classified (HNOC) or not covered by GHS
Reacts violently with water.

SECTION 3. COMPOSITION/INFORMATION ON INGREDIENTS

3.1 Substances
Formula : Na2ZrF6F6Na2Zr
Molecular weight : 251.19 g/mol
CAS-No. : 16925-26-1
EC-No. : 240-990-3
Hazardous components
Component Classification Concentration
Sodium hexafluorozirconate
Skin Corr. 1B; Eye Dam. 1;
H314
<= 100 %

SECTION 4. FIRST AID MEASURES

4.1 Description of first aid measures
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.Move out of dangerous area.Hydrofluoric
(HF) acid burns require immediate and specialized first aid and medical treatment. Symptoms may be delayed up to 24
hours depending on the concentration of HF. After decontamination with water, further damage can occur due to
penetration/absorption of the fluoride ion. Treatment should be directed toward binding the fluoride ion as well as the
effects of exposure. Skin exposures can be treated with a 2.5% calcium gluconate gel repeated until burning ceases.
More serious skin exposures may require subcutaneous calcium gluconate except for digital areas unless the physician
is experienced in this technique, due to the potential for tissue injury from increased pressure. Absorption can readily
occur through the subungual areas and should be considered when undergoing decontamination. Prevention of
absorption of the fluoride ion in cases of ingestion can be obtained by giving milk, chewable calcium carbonate tablets
or Milk of Magnesia to conscious victims. Conditions such as hypocalcemia, hypomagnesemia and cardiac arrhythmias
should be monitored for, since they can occur after exposure.Hydrofluoric (HF) acid burns require immediate and
specialized first aid and medical treatment. Symptoms may be delayed up to 24 hours depending on the concentration
of HF. After decontamination with water, further damage can occur due to penetration/absorption of the fluoride ion.
Treatment should be directed toward binding the fluoride ion as well as the effects of exposure. Skin exposures can be
treated with a 2.5% calcium gluconate gel repeated until burning ceases. More serious skin exposures may require
subcutaneous calcium gluconate except for digital areas unless the physician is experienced in this technique, due to
the potential for tissue injury from increased pressure. Absorption can readily occur through the subungual areas and
should be considered when undergoing decontamination. Prevention of absorption of the fluoride ion in cases of
ingestion can be obtained by giving milk, chewable calcium carbonate tablets or Milk of Magnesia to conscious victims.
Conditions such as hypocalcemia, hypomagnesemia and cardiac arrhythmias should be monitored for, since they can
occur after exposure.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
In case of skin contact
Take off contaminated clothing and shoes immediately. Wash off with soap and plenty of water. Consult a
physician.First treatment with calcium gluconate paste.
In case of eye contact
Rinse thoroughly with plenty of water for at least 15 minutes and consult a physician.Continue rinsing eyes during
transport to hospital.
If swallowed
Do NOT induce vomiting. Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a
physician.
4.2 Most important symptoms and effects, both acute and delayed
The most important known symptoms and effects are described in the labelling (see section 2.2) and/or in section 11
4.3 Indication of any immediate medical attention and special treatment needed
No data available

SECTION 5. FIREFIGHTING MEASURES

5.1 Extinguishing media
Suitable extinguishing media
Dry powder
5.2 Special hazards arising from the substance or mixture
No data available
5.3 Advice for firefighters
Wear self-contained breathing apparatus for firefighting if necessary.
5.4 Further information
No data available

SECTION 6. ACCIDENTAL RELEASE MEASURES

6.1 Personal precautions, protective equipment and emergency procedures
Use personal protective equipment. Avoid dust formation. Avoid breathing Vapors, mist or gas. Ensure adequate
ventilation. Evacuate personnel to safe areas. Avoid breathing dust.
For personal protection see section 8.
6.2 Environmental precautions
Do not let product enter drains.
6.3 Methods and materials for containment and cleaning up
Pick up and arrange disposal without creating dust. Sweep up and shovel. Do not flush with water. Keep in suitable,
closed containers for disposal.
6.4 Reference to other sections
For disposal see section 13.

SECTION 7. HANDLING AND STORAGE

7.1 Precautions for safe handling
Avoid formation of dust and aerosols.
Provide appropriate exhaust ventilation at places where dust is formed.
For precautions see section 2.2.
7.2 Conditions for safe storage, including any incompatibilities
Keep container tightly closed in a dry and well-ventilated place.
Never allow product to get in contact with water during storage.
7.3 Specific end use(s)
Apart from the uses mentioned in section 1.2 no other specific uses are stipulated

SECTION 8. EXPOSURE CONTROLS/PERSONAL PROTECTION

8.1 Control parameters
Components with workplace control parameters
Component CAS-No. Value Control
parameters
Basis
Sodium
hexafluorozirconate
16925-26-1 TWA 5.000000
mg/m3
USA. Occupational Exposure Limits
(OSHA) - Table Z-1 Limits for Air
Contaminants
TWA 5.000000
mg/m3
USA. ACGIH Threshold Limit Values
(TLV)
Remarks Not classifiable as a human carcinogen
STEL 10.000000
mg/m3
USA. ACGIH Threshold Limit Values
(TLV)
Not classifiable as a human carcinogen
TWA 5.000000
mg/m3
USA. NIOSH Recommended
Exposure Limits
ST 10.000000
mg/m3
USA. NIOSH Recommended
Exposure Limits
TWA 5 mg/m3 USA. Occupational Exposure Limits
(OSHA) - Table Z-1 Limits for Air
Contaminants
TWA 5 mg/m3 USA. ACGIH Threshold Limit Values
(TLV)
Not classifiable as a human carcinogen
STEL 10 mg/m3 USA. ACGIH Threshold Limit Values
(TLV)
Not classifiable as a human carcinogen
TWA 5 mg/m3 USA. NIOSH Recommended
Exposure Limits
ST 10 mg/m3 USA. NIOSH Recommended
Exposure Limits
8.2 Exposure controls
Appropriate engineering controls
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and at the end of
workday.
Personal protective equipment
Eye/face protection
Face shield and safety glasses Use equipment for eye protection tested and approved under appropriate
government standards such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique (without
touching glove's outer surface) to avoid skin contact with this product. Dispose of contaminated gloves after
use in accordance with applicable laws and good laboratory practices. Wash and dry hands.
Body Protection
Complete suit protecting against chemicals, Flame retardant protective clothing, The type of protective
equipment must be selected according to the concentration and amount of the dangerous substance at the
specific workplace.
Respiratory protection
Where risk assessment shows air-purifying respirators are appropriate use a full-face particle respirator type
N100 (US) or type P3 (EN 143) respirator cartridges as a backup to engineering controls. If the respirator is the
sole means of protection, use a full-face supplied air respirator. Use respirators and components tested and
approved under appropriate government standards such as NIOSH (US) or CEN (EU).
Control of environmental exposure
Do not let product enter drains.

SECTION 9. PHYSICAL AND CHEMICAL PROPERTIES

9.1 Information on basic physical and chemical properties
a) Appearance Form: solid
b) Odor No data available
c) Odor Threshold No data available
d) pH No data available
e) Melting point/freezing
point
No data available
f) Initial boiling point and
boiling range
No data available
g) Flash point No data available
h) Evaporation rate No data available
i) Flammability (solid, gas) No data available
j) Upper/lower
flammability or
explosive limits
No data available
k) Vapor pressure No data available
l) Vapor density 8.67 - (Air = 1.0)
m) Relative density No data available
n) Water solubility No data available
o) Partition coefficient: noctanol/
water
No data available
p) Auto-ignition
temperature
No data available
q) Decomposition
temperature
No data available
r) Viscosity No data available
s) Explosive properties No data available
t) Oxidizing properties No data available
9.2 Other safety information
Relative Vapor density 8.67 - (Air = 1.0)

SECTION 10. STABILITY AND REACTIVITY

10.1 Reactivity
No data available
10.2 Chemical stability
Stable under recommended storage conditions.
10.3 Possibility of hazardous reactions
Reacts violently with water.
10.4 Conditions to avoid
Exposure to moisture
10.5 Incompatible materials
Strong oxidizing agents
10.6 Hazardous decomposition products
Other decomposition products - No data available
Hazardous decomposition products formed under fire conditions. - Hydrogen fluoride, Sodium oxides, Zirconium oxides
In the event of fire: see section 5

SECTION 11. TOXICOLOGICAL INFORMATION

11.1 Information on toxicological effects
Acute toxicity
No data available
Inhalation: No data available
Dermal: No data available
No data available
Skin corrosion/irritation
No data available
Serious eye damage/eye irritation
No data available
Respiratory or skin sensitisation
No data available
Germ cell mutagenicity
No data available
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
NTP: No component of this product present at levels greater than or equal to 0.1% is identified as a
known or anticipated carcinogen by NTP.
OSHA: No component of this product present at levels greater than or equal to 0.1% is identified as a
carcinogen or potential carcinogen by OSHA.
Reproductive toxicity
No data available
No data available
Specific target organ toxicity - single exposure
No data available
Specific target organ toxicity - repeated exposure
No data available
Aspiration hazard
No data available
Additional Information
RTECS: Not available
Fluoride ion can reduce serum calcium levels possibly causing fatal hypocalcemia.
Fluoride ion can reduce serum calcium levels possibly causing fatal hypocalcemia.
Salivation, Nausea, Abdominal pain, Vomiting, Fever, Rapid respiration, Fluoride ion can reduce serum calcium levels
possibly causing fatal hypocalcemia., Material is extremely destructive to tissue of the mucous membranes and upper
respiratory tract, eyes, and skin., spasm, inflammation and edema of the larynx, spasm, inflammation and edema of the
bronchi, pneumonitis, pulmonary edema, burning sensation

SECTION 12. ECOLOGICAL INFORMATION

12.1 Toxicity
No data available
12.2 Persistence and degradability
No data available
12.3 Bioaccumulative potential
No data available
12.4 Mobility in soil
No data available
12.5 Results of PBT and vPvB assessment
PBT/vPvB assessment not available as chemical safety assessment not required/not conducted
12.6 Other adverse effects
No data available

SECTION 13. DISPOSAL CONSIDERATIONS

13.1 Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company. Contact a licensed professional waste
disposal service to dispose of this material. Dissolve or mix the material with a combustible solvent and burn in a
chemical incinerator equipped with an afterburner and scrubber.
Contaminated packaging
Dispose of as unused product.

SECTION 14. TRANSPORT INFORMATION

DOT (US)
UN number: 3288 Class: 6.1 Packing group: III
Proper shipping name: Toxic solid, inorganic, n.o.s. (Sodium hexafluorozirconate)
Reportable Quantity (RQ):
Poison Inhalation Hazard: No
IMDG
UN number: 3288 Class: 6.1 Packing group: III EMS-No: F-A, S-A
Proper shipping name: TOXIC SOLID, INORGANIC, N.O.S. (Sodium hexafluorozirconate)
IATA
UN number: 3288 Class: 6.1 Packing group: III
Proper shipping name: Toxic solid, inorganic, n.o.s. (Sodium hexafluorozirconate)

SECTION 15. REGULATORY INFORMATION

SARA 302 Components
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section 302.
SARA 313 Components
This material does not contain any chemical components with known CAS numbers that exceed the threshold (De
Minimis) reporting levels established by SARA Title III, Section 313.
SARA 311/312 Hazards
Acute Health Hazard
Massachusetts Right To Know Components
No components are subject to the Massachusetts Right to Know Act.
Pennsylvania Right To Know Components
Sodium hexafluorozirconate
CAS-No.
16925-26-1
Revision Date
New Jersey Right To Know Components
Sodium hexafluorozirconate
CAS-No.
16925-26-1
Revision Date
California Prop. 65 Components
This product does not contain any chemicals known to State of California to cause cancer, birth defects, or any other
reproductive harm.

SECTION 16. OTHER INFORMATION

Safety Data Sheet according to Regulation (EC) No. 1907/2006 (REACH). The above information is believed to be correct but does not purport to be all inclusive and shall be used only as a guide. The information in this document is based on the present state of our knowledge and is applicable to the product with regard to appropriate safety precautions. It does not represent any guarantee of the properties of the product. American Elements shall not be held liable for any damage resulting from handling or from contact with the above product. See reverse side of invoice or packing slip for additional terms and conditions of sale. COPYRIGHT 1997-2022 AMERICAN ELEMENTS. LICENSED GRANTED TO MAKE UNLIMITED PAPER COPIES FOR INTERNAL USE ONLY.